board WHOcte. Soft tissue and bone tumours. 5th ed ed. World Health Organization classification of tumours. World Health Organization International Agency for Research on Cancer; 2020.

dos Santos NR, de Bruijn DR, van Kessel AG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer. 2001;30(1):1–14. https://doi.org/10.1002/1098-2264(2000)9999:9999%3c::aid-gcc1056%3e3.0.co;2-g.

Article  PubMed  Google Scholar 

Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62(1):135–40.

CAS  PubMed  Google Scholar 

Stacchiotti S, Van Tine BA. Synovial sarcoma: current concepts and future perspectives. J Clin Oncol. 2018;36(2):180–7. https://doi.org/10.1200/jco.2017.75.1941.

Article  CAS  PubMed  Google Scholar 

Jones KB, Barrott JJ, Xie M, Haldar M, Jin H, Zhu JF, et al. The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis. Oncogene. 2016;35(38):5021–32. https://doi.org/10.1038/onc.2016.38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kadoch C, Crabtree GR. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell. 2013;153(1):71–85. https://doi.org/10.1016/j.cell.2013.02.036.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoang NT, Acevedo LA, Mann MJ, Tolani B. A review of soft-tissue sarcomas: translation of biological advances into treatment measures. Cancer Manag Res. 2018;10:1089–114. https://doi.org/10.2147/cmar.S159641.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mastrangelo G, Coindre JM, Ducimetière F, Dei Tos AP, Fadda E, Blay JY, et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer. 2012;118(21):5339–48. https://doi.org/10.1002/cncr.27555.

Article  PubMed  Google Scholar 

Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int J Cancer. 2006;119(12):2922–30. https://doi.org/10.1002/ijc.22239.

Article  CAS  PubMed  Google Scholar 

Sultan I, Rodriguez-Galindo C, Saab R, Yasir S, Casanova M, Ferrari A. Comparing children and adults with synovial sarcoma in the surveillance, epidemiology, and end results program, 1983 to 2005: an analysis of 1268 patients. Cancer. 2009;115(15):3537–47. https://doi.org/10.1002/cncr.24424.

Article  PubMed  Google Scholar 

Blay JY, von Mehren M, Jones RL, Martin-Broto J, Stacchiotti S, Bauer S, et al. Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies. ESMO Open. 2023;8(5): 101618. https://doi.org/10.1016/j.esmoop.2023.101618.

Article  PubMed  PubMed Central  Google Scholar 

Ferrari A, Gronchi A, Casanova M, Meazza C, Gandola L, Collini P, et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer. 2004;101(3):627–34. https://doi.org/10.1002/cncr.20386.

Article  PubMed  Google Scholar 

Palmerini E, Staals EL, Alberghini M, Zanella L, Ferrari C, Benassi MS, et al. Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution. Cancer. 2009;115(13):2988–98. https://doi.org/10.1002/cncr.24370.

Article  PubMed  Google Scholar 

Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18(6):812–22. https://doi.org/10.1016/s1470-2045(17)30334-0.

Article  CAS  PubMed  Google Scholar 

Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up(☆). Ann Oncol. 2021;32(11):1348–65. https://doi.org/10.1016/j.annonc.2021.07.006.

Article  CAS  PubMed  Google Scholar 

Vlenterie M, Ho VK, Kaal SE, Vlenterie R, Haas R, van der Graaf WT. Age as an independent prognostic factor for survival of localised synovial sarcoma patients. Br J Cancer. 2015;113(11):1602–6. https://doi.org/10.1038/bjc.2015.375.

Article  PubMed  PubMed Central  Google Scholar 

Guillou L, Benhattar J, Bonichon F, Gallagher G, Terrier P, Stauffer E, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004;22(20):4040–50. https://doi.org/10.1200/jco.2004.11.093.

Article  PubMed  Google Scholar 

ten Heuvel SE, Hoekstra HJ, Bastiaannet E, Suurmeijer AJ. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression. Appl Immunohistochem Mol Morphol. 2009;17(3):189–95. https://doi.org/10.1097/PAI.0b013e31818a6f5c.

Article  CAS  PubMed  Google Scholar 

Bairoch A. The cellosaurus, a cell-line knowledge resource. J Biomol Tech. 2018;29(2):25–38. https://doi.org/10.7171/jbt.18-2902-002.

Article  PubMed  PubMed Central  Google Scholar 

Ben-David U, Beroukhim R, Golub TR. Genomic evolution of cancer models: perils and opportunities. Nat Rev Cancer. 2019;19(2):97–109. https://doi.org/10.1038/s41568-018-0095-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560(7718):325–30. https://doi.org/10.1038/s41586-018-0409-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Osaki J, Noguchi R, Yanagihara K, Ono T, Adachi Y, Iwata S, et al. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma. Hum Cell. 2024. https://doi.org/10.1007/s13577-024-01039-0.

Article  PubMed  Google Scholar 

Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, et al. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018;31(2):167–74. https://doi.org/10.1007/s13577-018-0199-9.

Article  CAS  PubMed  Google Scholar 

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, et al. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018;54(5):392–9. https://doi.org/10.1007/s11626-018-0237-7.

Article  CAS  PubMed  Google Scholar 

Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, et al. Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2020;33(3):877–85. https://doi.org/10.1007/s13577-020-00354-6.

Article  CAS  PubMed  Google Scholar 

Tsuchiya R, Yoshimatsu Y, Noguchi R, Ono T, Sei A, Takeshita F, et al. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2021;34(3):998–1007. https://doi.org/10.1007/s13577-021-00509-z.

Article  CAS  PubMed  Google Scholar 

Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, et al. Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2022;35(4):1290–7. https://doi.org/10.1007/s13577-022-00721-5.

Article  CAS  PubMed  Google Scholar 

Trédan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 2007;99(19):1441–54. https://doi.org/10.1093/jnci/djm135.

Article  CAS  PubMed  Google Scholar